Tag: Breast Cancer
-

How My Mother Carried Me Through My Mastectomy
Beginning the Quiet Work of Healing I didn’t know where to begin when the idea of a mastectomy finally settled into my daily reality. The weeks before the surgery felt like a long, unfinished sentence, the kind you can’t quite finish aloud. It takes weeks after the fact to summon the bravery to glimpse the…
-

Olive Oil and Breast Cancer Risk: EVOO Benefits & Mechanisms
Overview: EVOO and Breast Cancer Risk Numerous studies suggest that extra-virgin olive oil (EVOO), a cornerstone of the Mediterranean diet, is associated with a reduced risk of developing breast cancer. It is important to note that EVOO is not a cure or treatment. Rather, its regular inclusion in a balanced diet may contribute to a…
-

My Mastectomy Recovery: How My Mother Helped Me Heal
Facing the Mirror, Facing the Truth I write this as a daily confession to a life altered by mastectomy, a road I didn’t choose but am learning to walk. Weeks ago, I recoiled from the space where my right breast used to be, a hollow in the memory of my own body. I study the…
-

My Late Mother’s Light: Through My Mastectomy
Introduction: A Quiet Presence When I faced a mastectomy, the space where my right breast once lived felt like a wound that wouldn’t quite heal. Yet in the days that followed, I discovered that healing isn’t only physical; it is carried in the quiet acts of love we’ve carried with us for years. My mother’s…
-

CTHRC1-driven Breast Cancer Progression: Palmitoylation Networks and Spatial Heterogeneity
Overview: Unraveling CTHRC1’s Role in Breast Cancer Breast cancer remains the most common malignancy affecting women worldwide, demanding deeper insights into its molecular drivers. Among emerging players, CTHRC1 has gained attention for its potential to modulate tumor progression through diverse signaling circuits. This article synthesizes current knowledge on how CTHRC1 influences breast cancer dynamics, with…
-

CTHRC1-driven breast cancer progression: palmitoylation networks and spatial heterogeneity
Understanding CTHRC1 in breast cancer progression Breast cancer remains the leading malignancy among women worldwide, driving urgent research into its molecular underpinnings and how these insights can translate into better diagnostics and therapies. Among the emerging molecular players, CTHRC1 (Collagen Triple Helix Repeat Containing 1) has attracted attention for its potential role in promoting tumor…
-

Amy Dowden Shares Health Update Two Weeks After Second Mastectomy
Dancing Through Adversity: Amy Dowden’s Health Update Strictly Come Dancing star Amy Dowden has given fans a hopeful health update, marking two weeks since she underwent a second mastectomy. The professional dancer, who publicly shared her breast cancer diagnosis in May 2023, has been open about the challenging journey and the medical steps she has…
-

Amy Dowden Shares Health Update as She Marks Two Weeks Since Second Mastectomy
Two Weeks After a Second Mastectomy: Amy Dowden Opens Up About Her Journey Professional dancer Amy Dowden has used her social media platform to share an intimate health update, two weeks after undergoing a second mastectomy following her breast cancer diagnosis. The news has resonated with fans and fellow artists who have followed her brave…
-

Proud of how far I’ve come: Amy Dowden shares health update two weeks after second mastectomy
Two weeks on: a candid health update from Amy Dowden Professional dancer and Strictly Come Dancing star Amy Dowden marked a significant milestone this week, sharing a health update as she reaches two weeks since her second mastectomy. Diagnosed with breast cancer in 2023, Dowden has faced a challenging journey with grace, resilience, and the…
-

Transitional Access: Taxpayer-Funded Cancer Medicine Expands to Private Hospitals for Advanced Breast Cancer Patients
What is transitional access and why it matters Transitional access refers to a temporary policy allowing taxpayers to fund a medicine in settings outside the usual public system—specifically, private hospitals. In the case of advanced breast cancer, this means that a groundbreaking drug, previously available only through public channels, can now be prescribed and funded…
